These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 19763049)

  • 21. Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial.
    Abdulla S; Sagara I; Borrmann S; D'Alessandro U; González R; Hamel M; Ogutu B; Mårtensson A; Lyimo J; Maiga H; Sasi P; Nahum A; Bassat Q; Juma E; Otieno L; Björkman A; Beck HP; Andriano K; Cousin M; Lefèvre G; Ubben D; Premji Z
    Lancet; 2008 Nov; 372(9652):1819-27. PubMed ID: 18926569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized clinical trial comparing safety, clinical and parasitological response to artemether-lumefantrine and chlorproguanil-dapsone in treatment of uncomplicated malaria in pregnancy in Mulago hospital, Uganda.
    Kaye DK; Nshemerirwe R; Mutyaba TS; Ndeezi G
    J Infect Dev Ctries; 2008 Apr; 2(2):135-9. PubMed ID: 19738339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of weight, age, and time on artemether-lumefantrine associated ototoxicity and evidence of irreversibility.
    Toovey S
    Travel Med Infect Dis; 2006 Mar; 4(2):71-6. PubMed ID: 16887727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and effectiveness of artemether-lumefantrine after initial and repeated treatment in children <5 years of age with acute uncomplicated Plasmodium falciparum malaria in rural Tanzania: a randomized trial.
    Ngasala BE; Malmberg M; Carlsson AM; Ferreira PE; Petzold MG; Blessborn D; Bergqvist Y; Gil JP; Premji Z; Björkman A; Mårtensson A
    Clin Infect Dis; 2011 Apr; 52(7):873-82. PubMed ID: 21427394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Riamet: a new antimalarial for curative treatment of malaria].
    Delhaes L; Frealle E; Dutoit E; Camus D
    Med Trop (Mars); 2002; 62(5):485-7. PubMed ID: 12616938
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia.
    Denis MB; Tsuyuoka R; Lim P; Lindegardh N; Yi P; Top SN; Socheat D; Fandeur T; Annerberg A; Christophel EM; Ringwald P
    Trop Med Int Health; 2006 Dec; 11(12):1800-7. PubMed ID: 17176344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of the therapeutic efficacy of a paediatric formulation of artemether-lumefantrine (Coartesiane) for the treatment of uncomplicated Plasmodium falciparum in children in Zambia.
    Chanda P; Hawela M; Kango M; Sipilanyambe N
    Malar J; 2006 Aug; 5():75. PubMed ID: 16938133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coartemether (artemether and lumefantrine): an oral antimalarial drug.
    Wernsdorfer WH
    Expert Rev Anti Infect Ther; 2004 Apr; 2(2):181-96. PubMed ID: 15482185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh.
    Haque R; Thriemer K; Wang Z; Sato K; Wagatsuma Y; Salam MA; Akther S; Akter J; Fukuda M; Miller RS; Noedl H
    Am J Trop Med Hyg; 2007 Jan; 76(1):39-41. PubMed ID: 17255226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High efficacy of two artemisinin-based combinations (artemether-lumefantrine and artesunate plus amodiaquine) for acute uncomplicated malaria in Ibadan, Nigeria.
    Falade CO; Ogundele AO; Yusuf BO; Ademowo OG; Ladipo SM
    Trop Med Int Health; 2008 May; 13(5):635-43. PubMed ID: 18346028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haemolytic anaemia after oral artemether-lumefantrine treatment in a patient affected by severe imported falciparum malaria.
    De Nardo P; Oliva A; Giancola ML; Ghirga P; Mencarini P; Bibas M; Nicastri E; Antinori A; Corpolongo A
    Infection; 2013 Aug; 41(4):863-5. PubMed ID: 23553281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania.
    Kabanywanyi AM; Mwita A; Sumari D; Mandike R; Mugittu K; Abdulla S
    Malar J; 2007 Nov; 6():146. PubMed ID: 17996121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of a pre-season treatment with effective antimalarials on subsequent malaria morbidity in under five-year-old children living in high and seasonal malaria transmission area of Burkina Faso.
    Ouédraogo A; Tiono AB; Diarra A; Nébié IO; Konaté AT; Sirima SB
    Trop Med Int Health; 2010 Nov; 15(11):1315-21. PubMed ID: 20958888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial.
    Piola P; Fogg C; Bajunirwe F; Biraro S; Grandesso F; Ruzagira E; Babigumira J; Kigozi I; Kiguli J; Kyomuhendo J; Ferradini L; Taylor W; Checchi F; Guthmann JP
    Lancet; 2005 Apr 23-29; 365(9469):1467-73. PubMed ID: 15850630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro sensitivity of Plasmodium falciparum to lumefantrine in north-western Thailand.
    Pilz JB; Wernsdorfer G; Sirichaisinthop J; Rojanawatsirivet C; Wiedermann G; Wernsdorfer WH
    Wien Klin Wochenschr; 2004; 116 Suppl 4():41-6. PubMed ID: 15683042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adherence and efficacy of supervised versus non-supervised treatment with artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh: a randomised controlled trial.
    Rahman MM; Dondorp AM; Day NP; Lindegardh N; Imwong M; Faiz MA; Bangali AM; Kamal AT; Karim J; Kaewkungwal J; Singhasivanon P
    Trans R Soc Trop Med Hyg; 2008 Sep; 102(9):861-7. PubMed ID: 18606428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First artemisinin-based antimalarial combination approved for U.S. market.
    Thompson CA
    Am J Health Syst Pharm; 2009 May; 66(10):880. PubMed ID: 19420302
    [No Abstract]   [Full Text] [Related]  

  • 38. No hearing loss associated with the use of artemether-lumefantrine to treat experimental human malaria.
    McCall MB; Beynon AJ; Mylanus EA; van der Ven AJ; Sauerwein RW
    Trans R Soc Trop Med Hyg; 2006 Dec; 100(12):1098-104. PubMed ID: 16808940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surveillance for the safety and effectiveness of artemether-lumefantrine in patients with uncomplicated Plasmodium falciparum malaria in the USA: a descriptive analysis.
    Gray AM; Arguin PM; Hamed K
    Malar J; 2015 Sep; 14():349. PubMed ID: 26377423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of food consumption on lumefantrine bioavailability in African children receiving artemether-lumefantrine crushed or dispersible tablets (Coartem) for acute uncomplicated Plasmodium falciparum malaria.
    Borrmann S; Sallas WM; Machevo S; González R; Björkman A; Mårtensson A; Hamel M; Juma E; Peshu J; Ogutu B; Djimdé A; D'Alessandro U; Marrast AC; Lefèvre G; Kern SE
    Trop Med Int Health; 2010 Apr; 15(4):434-41. PubMed ID: 20180933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.